Which medications in the drug class Leukotriene Receptor Antagonists are used in the treatment of Chronic Urticaria?

Updated: Jul 31, 2018
  • Author: Marla N Diakow, MD; Chief Editor: William D James, MD  more...
  • Print
Answer

Leukotriene Receptor Antagonists

Leukotriene antagonists have been shown to be superior to placebo in the treatment of patients with chronic urticaria but are considered less effective than nonsedating antihistamines; however, the 2 classes of agents can be combined. Montelukast 10 mg/day may be particularly helpful for patients experiencing flare-ups due to aspirin or other NSAIDs. Montelukast is approved for treatment of perennial allergic rhinitis in children aged 6 months and older.

Montelukast (Singulair)

Montelukast is a selective competitive inhibitor of the cysteinyl leukotriene receptor. Montelukast is the last agent introduced in its class. The advantages are that it is chewable, it has a once-a-day dosing, and it has no significant adverse effects.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!